Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma

NCT05425004 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT05425004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05425004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Cabozantinib for Patients With Recurrent or Progressive Meningioma
Lead sponsor
Baptist Health South Florida
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2022
Completion date
May 31, 2028
Enrollment
24 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

meningioma